ArticlePediatric research2026
Structured implementation of a bubble-CPAP program to reduce bronchopulmonary dysplasia in preterm infants.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan.Paediatric respiratory reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCPAP effectiveness may depend not only on the device itself, but also on implementation. We hypothesized that structured implementation would be associated with improved outcomes. This study describes a bubble-CPAP (b-CPAP) program-including training, guidelines, skills practice, and checklists-and evaluates its clinical correlates.
methodsThis study describes b-CPAP program implementation. The study included all preterm infants with birthweight <1500 g. Infants were excluded if gestational age <22 weeks, died in the delivery room before NICU admission, had genetic conditions or surgical conditions requiring transfer. Data were collected from January 2016 through December 2022. Outcomes before and after implementation were compared using bivariate and logistic regression analyses while adjusting for potential confounders.
resultsAmong 903 infants, survival without BPD improved from 59% to 74% (aOR=1.86, 95% CI: 1.25-2.76, p = 0.01), and BPD rates decreased from 25.2% to 6.9% (aOR = 0.12, 95% CI:0.06-0.26, p < 0.001). Median oxygen use decreased from 26 (4-70) days to 15 (4-42) days (p = 0.03), and CPAP use increased from 10 (5-19) days to 27 (10-39) days (p < 0.0001). The incidence of pneumothorax did not change (4.1% to 6.4%, aOR = 1.59, 95% CI:0.80-3.18, p = 0.18).
conclusionStepwise implementation of a structured b-CPAP program was associated with substantial improvements in survival without BPD and BPD rates. IMPACT: Bronchopulmonary dysplasia (BPD) remains a major complication in premature infants, affecting approximately 40% of infants born under 1000 grams. While RCTs showed only modest benefit of early CPAP, observational studies reported greater improvements, underscoring the importance of consistent implementation beyond initial use. Structured stepwise implementation of the b-CPAP program was associated with improved survival without BPD and reduced BPD prevalence. The findings may inform future strategies to enhance reproducibility and effectiveness of CPAP use through systematic implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.